Showing results (511-520 of 539) with videos related to

Sort By:
Pageof 54
British Journal of Cancer|February 8, 2007
Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinomaM F Ji, D K Wang, Y L Yu, et al.
Journal of Pediatric Surgery|December 17, 2009
Pediatric liver transplantation in Hong Kong-a domain with scarce deceased donorsKwong Leung Chan, Sheung Tat Fan, Chung Mau Lo, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 6, 2026
Oral Magnetoelectric Neuroimmunomodulation via the Gut-Brain-Spleen-Heart Axis for Noninvasive Atrial Fibrillation TherapyCam-Hoa Mac, Chen-Hsuan Kuo, I-Wei Wang, et al.
Clinical and Molecular Hepatology|October 17, 2024
Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trialYao-Chun Hsu, Chi-Yi Chen, Cheng-Hao Tseng, et al.
Head & Neck|October 22, 2005
Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all?Phillip K Pellitteri, Alfio Ferlito, Alessandra Rinaldo, et al.
Nature Communications|May 8, 2024
Flash heating process for efficient meat preservationYimin Mao, Peihua Ma, Tangyuan Li, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 12, 2026
Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcinoma: A retrospective multi-center cohortI-Wei Ho, Chung-Pin Li, Shih-Hung Yang, et al.
Physical Review Letters|August 8, 2022
Gapped Collective Charge Excitations and Interlayer Hopping in Cuprate SuperconductorsM Hepting, M Bejas, A Nag, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2026
SLOG versus modified FOLFIRINOX as first-line treatment for advanced pancreatic cancer: A randomized phase II trial (TCOG T5217)Nai-Jung Chiang, Yung-Yeh Su, I-Wei Ho, et al.
Pageof 54